✦ LIBER ✦

An open-label Phase I/II clinical trial of pyrimethamine for the treatment of patients affected with chronic GM2 gangliosidosis (Tay–Sachs or Sandhoff variants)

✍ Scribed by Joe T.R. Clarke; Don J. Mahuran; Swati Sathe; Edwin H. Kolodny; Brigitte A. Rigat; Julian A. Raiman; Michael B. Tropak

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label phase I/II clinical trial

✍ Joe Clarke; Don Mahuran; Swati Sathe; Edwin Kolodny; Brigitte Rigat; Julian Raim 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

30. Open-label Phase I/II clinical trial

✍ Joe Clarke; Edwin Kolodny; Don Mahuran; Maria Fuller; Michael Tropak; Jack Keime 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB